RESEARCH: Interview Bob Proulx, CEO Imagion Biosystems

This story features IMAGION BIOSYSTEMS LIMITED. For more info SHARE ANALYSIS: IBX

Interview with Bob Proulx, CEO Imagion Biosystems

By Pitt Street Research

Imagion Biosystems: Breakthrough imaging technology
 
We spoke with Bob Proulx, CEO Imagion Biosystems ((IBX)), about Imagion's revolutionary MagSense imaging technology, which is potentially orders of magnitude more effective than CT and MRI at detecting cancer.

MagSense was granted Breakthrough Device status by the FDA in June 2019 and is currently being prepared for its first clinical study, potentially in Her2-positive breast cancer.

Watch the whole interview through the link below.

https://www.pittstreetresearch.com/imagion-biosystems

Last week the video above was released by Pitt Street Research for which FNArena is a partner in distribution.

Find out why FNArena subscribers like the service so much: "Your Feedback (Thank You)" – Warning this story contains unashamedly positive feedback on the service provided.

FNArena is proud about its track record and past achievements: Ten Years On

Click to view our Glossary of Financial Terms